Phase 2 trial (NEJM, 2023) The landmark Phase 2 trial, published in the New England Journal of Medicine, randomized 338 adults with obesity to receive weekly subcutaneous retatrutide at doses of 1 mg, 4 mg, 8 mg, or 12 mg, or placebo, for 48 weeks
The Future of Longevity Research PRG is an educational platform focused on peptide science, longevity research, mitochondrial biology, metabolic signaling, and related scientific topics
We ensure the amino-acid sequencing is exact and that purity levelsverified through rigorous testingare consistently high
This helps you compare how different vial strengths behave at the same concentration, making it easier to plan purchases or understand how concentration affects various vial sizes
Vitamin B12 is a key nutrient involved in red blood cell production, neurological health, and metabolic function
Breastfeeding Walcobal Injection is generally considered safe during breastfeeding, but it's always a good idea to consult your doctor